New Salonpas(R) DEEP Relieving Gel: A Powerful Topical Analgesic Innovation

FLORHAM PARK, NJ--(Marketwired - Jul 22, 2013) - Hisamitsu America, a division of Hisamitsu Pharmaceutical Co., Inc., and the manufacturers of Salonpas^®, the one and only OTC pain patch that is FDA approved and clinically proven, maintains their commitment to providing industry leading, topical analgesic solutions with the launch today of Salonpas^® DEEP Relieving Gel.

"Transdermal creams, gels, foam and patches offer a unique way of delivering medication to your body which offers significant advantages over taking medications orally," says Dr. Sylvia Hesse, who is an orthopedic medicine specialist at Manhattan Spine & Sports Medicine. "One of the biggest advantages is that the medication is delivered directly to the site of pain. Direct application allows a higher concentration of the drug to reach the tissue that needs it. The total amount of medication absorbed into the bloodstream is low, leading to a very low incidence of side effects, in contrast to oral medications. Topical treatments can use less medicine and get the same or better relief."

"While many Americans still turn to over-the-counter pills to relieve pain, topical analgesic pain relief is gaining greater market recognition and we are proud to bring to market solutions that are well-tested and manufactured to the highest quality," said John Incledon, President & CEO, Hisamitsu America.

New Salonpas® DEEP Relieving Gel is available at leading retailers nationwide. Designed to penetrate deep to relieve the toughest muscle and joint pain, Salonpas® DEEP Relieving Gel is an easy-to-use topical analgesic that starts to delivers pain relief in seconds. With three active ingredients, camphor (3.1%), menthol (10%) and methyl salicylate (15%), DEEP Relieving Gel rushes strong medicine where you need it in a fast-melting, quick-absorbing, clear, non-greasy formulation.

About Hisamitsu America:
Hisamitsu America is the US division of Hisamitsu Pharmaceutical Co., Inc., founded in 1847, which has specialized in topical drug delivery technology since the introduction of its Salonpas line of patches in 1934. The SALONPAS^® product line, which gained early acceptance in Asia and now sells in 50 countries, has pioneered the development of topicalpatches to relieve everyday aches and pains. Today, the Salonpas® Pain Relief Patches are the first and only FDA-approved OTC pain patch. For more information, visit www.salonpas.us.